SARS-CoV-2: A Biochemical Treatise on its Past, Present & Future
Bio Spectrum|September 2021
The SARS-CoV-2 pandemic is unprecedented but equally unprecedented is the contribution of scientists who have helped us in understanding the mechanisms by which it infects human beings and also, developing a variety of vaccines to protect the masses, in a year’s time, which can be called truly groundbreaking. This article gives an overview of the progress made by scientists around the world working round the clock in developing an understanding of the SARS-CoV-2 evolution and COVID-19 disease pathogenesis, and also makes an attempt to suggest the possible ways of coping with this pandemic if we have to co-exist with it forever!
Dr Ashok Kumar
SARS-CoV-2: A Biochemical Treatise on its Past, Present & Future

As per the figures disclosed by the National Health Ministry (NHM), India has witnessed 400,000 excess deaths in April and May, 2021 in comparison with April and May 2020. And the surge in COVID-19, cases in Europe, the US and neighbouring countries reveals that the coronavirus is still amidst us and is thriving well! Since December 2019, with more than 188 million confirmed cases and more than 4.0 million deaths worldwide, as recorded on July 16, 2021, COVID-19 has severely disrupted human life, and we still don’t know for sure. The reasons why COVID-19 drastically affects some people, but the majority recovers whilst remaining largely asymptomatic. ‘How long will the immunity acquired after infection or the vaccination driven adaptive immunity be able to save us from reinfection?’ is a million-dollar question.

Why is SARS-CoV-2 so contagious?

Expedited sequencing of the viral genome, which proved that SAR-CoV-2 is similar to SARS (Severe Acute Respiratory Syndrome), the infection broke out in China between 2002 and 2004, also provided a clear understanding about the nature and mechanism by which SARS-CoV-2 spikes bind with Angiotensin-Converting Enzyme-2 (ACE-2), 10-20 times more effective than its predecessor, and how it gets quickly detached with the help of a protease allowing the lipid layer to fuse with the cell membrane and releasing its RNA into the host cell. Once inside, the virus replicates by simply hijacking the machinery of the host cells, thus spreading further and infecting more cells and eventually other organs, the transmission contaminating the environment and thus infecting more people. It’s again the understanding of the spike glycoproteins, which formed the basis for developing novel vaccines, in record times.

Denne historien er fra September 2021-utgaven av Bio Spectrum.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

Denne historien er fra September 2021-utgaven av Bio Spectrum.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

FLERE HISTORIER FRA BIO SPECTRUMSe alt
Agilent releases nextgen HPLC systems with enhanced automation and sustainability capabilities
Bio Spectrum

Agilent releases nextgen HPLC systems with enhanced automation and sustainability capabilities

Agilent Technologies Inc. has announced the release of its next generation Agilent InfinityLab LC Series portfolio, which includes the 1290 Infinity III LC, 1260 Infinity III Prime LC, and 1260 Infinity III LC systems, all including the biocompatible versions.

time-read
1 min  |
BioSpectrum India Dec 2024
Univercells Technologies launches miniaturised scale-X Nexo Bioreactor
Bio Spectrum

Univercells Technologies launches miniaturised scale-X Nexo Bioreactor

Univercells Technologies has announced the launch of its latest innovation, the scale-X nexo bioreactor.

time-read
1 min  |
BioSpectrum India Dec 2024
Thermo Fisher and Telangana to establish Bioprocess Design Centre for novel biotherapeutics
Bio Spectrum

Thermo Fisher and Telangana to establish Bioprocess Design Centre for novel biotherapeutics

Thermo Fisher Scientific has announced the signing of a Memorandum of Understanding (MoU) with the Government of Telangana to establish a Bioprocess Design Centre (BDC) in Genome Valley, Hyderabad.

time-read
1 min  |
BioSpectrum India Dec 2024
VFL Sciences announces launch of GreatFlo Parallel Bioreactors and Fermentors
Bio Spectrum

VFL Sciences announces launch of GreatFlo Parallel Bioreactors and Fermentors

Chennai-based VFL Sciences has announced the launch of GreatFlo Parallel, a range of seamlessly parallel Bioreactors and Fermentors at the IKMC 2024 event organised by IKP Knowledge Park at Hyderabad recently, by Dr Jitendra Kumar, Managing Director, BIRAC.

time-read
1 min  |
BioSpectrum India Dec 2024
Avantor opens new innovation centre for solving life science's biggest challenges
Bio Spectrum

Avantor opens new innovation centre for solving life science's biggest challenges

Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, has announced the opening of its new flagship Bridgewater Innovation Centre.

time-read
1 min  |
BioSpectrum India Dec 2024
Waters unveils new software to deliver lab-centric business intelligence
Bio Spectrum

Waters unveils new software to deliver lab-centric business intelligence

Waters Corporation has announced the launch of waters connect Data Intelligence software, a new cloud-based application that helps customers in regulated industries improve how they access, organise, analyse, and drive productivity from laboratory information.

time-read
1 min  |
BioSpectrum India Dec 2024
INST develops unique drug delivery method to improve treatment of brain TB
Bio Spectrum

INST develops unique drug delivery method to improve treatment of brain TB

Researchers at the Institute of Nano Science and Technology (INST), Mohali, have created a unique way to deliver Tuberculosis (TB) medicines directly to the brain bypassing the challenging blood-brain barrier (BBB) that limits the effectiveness of many brain TB medicines.

time-read
1 min  |
BioSpectrum India Dec 2024
New way to create hydrogels from viral protein fragments for improving drug delivery
Bio Spectrum

New way to create hydrogels from viral protein fragments for improving drug delivery

Researchers from Bose Institute, an autonomous institute of the Department of Science and Technology (DST), in Kolkata, have discovered a new way to create hydrogels using tiny protein fragments of just five amino acids from the SARS-CoV-1 virus, that could help improve targeted drug delivery & reduce side effects.

time-read
1 min  |
BioSpectrum India Dec 2024
Lupin appoints Claus Jepsen as President, Global Specialty
Bio Spectrum

Lupin appoints Claus Jepsen as President, Global Specialty

Global pharma major Lupin has announced the appointment of Claus Jepsen as President, Global Specialty.

time-read
1 min  |
BioSpectrum India Dec 2024
Shyamakant Giri to join as CEO of Gland Pharma
Bio Spectrum

Shyamakant Giri to join as CEO of Gland Pharma

Gland Pharma’s Board has approved the appointment of Shyamakant Giri, as the new Chief Executive Officer (CEO) of the company.

time-read
1 min  |
BioSpectrum India Dec 2024